Chief Development Officer
James Watson is Chief Development Officer for USACS. In this role, he is responsible for corporate strategy, mergers & acquisitions, and organic growth. As someone with both parents and siblings who are physicians in private practice, James is passionate about the difference that ownership makes in creating an industry-leading acute care partnership that is enduring for generations to come.
James joined USACS in February 2016 from EnvisionRx, a national pharmacy benefit manager, where he helped the company more than triple in size as head of corporate strategy and mergers & acquisitions. Prior to EnvisionRx, James was a healthcare private equity investment professional in San Francisco for TPG Capital, a private equity firm with over $60 billion in assets under management. Prior to TPG Capital, James was a healthcare investment banker for Goldman Sachs, based out of their New York City headquarters.
James graduated Phi Beta Kappa and Magna Cum Laude from Dartmouth College with a bachelor's degree in engineering.